Primary Site >> Colorectal Cancer
Gene >> CD247
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. PMID: 1465616 |
Ref: Decreased expression of the signal-transducing zeta chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. PMID: 8242612 |
Ref: The decreased expression of CD3 zeta chains in cancer patients is not reversed by IL-2 administration. PMID: 7989113 |
Ref: Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. PMID: 7790109 |
Ref: Interleukin 2 restores CD3-zeta chain expression but fails to generate tumour-specific lytic activity in tumour-infiltrating lymphocytes derived from human colorectal hepatic metastases. PMID: 9569042 |
Ref: A lack of evidence for down-modulation of CD3 zeta expression in colorectal carcinoma and pregnancy using multiple detection methods. PMID: 10540179 |
Ref: An entirely humanized CD3 zeta-chain signaling receptor that directs peripheral blood t cells to specific lysis of carcinoembryonic antigen-positive tumor cells. PMID: 10962448 |
Ref: Human natural killer cell line modified with a chimeric immunoglobulin T-cell receptor gene leads to tumor growth inhibition in vivo. PMID: 11960290 |
Ref: Adverse immunoregulatory effects of 5FU and CPT11 chemotherapy on myeloid-derived suppressor cells and colorectal cancer outcomes. PMID: 25209187 |
Ref: Immune response gene expression in colorectal cancer carries distinct prognostic implications according to tissue, stage and site: a prospective retrospective translational study in the context of a hellenic cooperative oncology group randomised trial. PMID: 25970543 |
Ref: Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic Implications. PMID: 26608909 |
Ref: Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell. PMID: 29790821 |